Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.

Clinical trial NCT06903312 · RECRUITING

Trial details

NCT number: NCT06903312
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Renal Cell Cancer Kidney Neoplasm Immunotherapy Kidney Cancer Surgery Programmed Radiotherapy

Start date: 2025-06-15
Primary completion: 2027-10-01
Enrollment: 409

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.